OUR PRODUCTS DEVELOPMENT COMPANY CAREERS COMPANY NEWS, PRESS RELEASES & EVENTS ARCHIVE View all of our news from our companys’ rich history. Select what you would like to see from the sorting filter below: SORTING CONTROLS NEWS PRESS RELEASES EVENTS & PRESENTATIONS Filter Your Results DATE RANGE WHAT ARE YOU LOOKING FOR? Subscribe NOTIFY ME WHEN NEW POSTS ARE PUBLISHED: SIGN ME UP! AUGUST 2, 2021 NEWS Delivering on the Promise of Nuclear Medicine: New Solutions for Patient Health This is an exciting time for nuclear medicine. PET and SPECT technologies are providing valuable insights about the molecular structure and function of the body and disease. Theranostics and therapeutic radiopharmaceuticals are expanding with growing scientific interest and public awareness. Read More… READ MORE » MAY 19, 2021 NEWS Beloit company reaches ‘major milestone’ in medical isotope production BELOIT — In what’s being hailed as “a major milestone for nuclear medicine,” NorthStar Medical Radioisotopes has received a pair of high-tech machines that will be used to produce radioactive material used in millions of medical procedures each year. The 24-ton particle accelerators arrived in Beloit Tuesday on flatbed trucks, capping a 5,700-mile journey from […] READ MORE » MAY 6, 2020 NEWS NorthStar construction, growth strong amid COVID-19 BELOIT — Company growth at NorthStar Medical Radioisotopes remains uninterrupted by COVID-19, according to CEO Steve Merrick. Work continues at the headquarters on a new electron accelerator production building to expand capacity of the company’s non-uranium domestic supply of molybdenum-99 (Mo-99). Read more… READ MORE » MARCH 5, 2020 NEWS NorthStar Expands Into Cardiac SPECT With New Licensing Deal NorthStar Medical Technologies is moving further into the cardiac imaging space after signing a new licensing agreement with St. Louis-based Capella Imaging, the companies announced Tuesday. As part of the deal, the Beloit, Wisconsin-based radioisotope company has acquired exclusive rights from Capella to develop and investigate a new fibrin-targeted diagnostic imaging agent used in single-photon […] READ MORE » FEBRUARY 20, 2020 NEWS Domestic Radioisotope Supply – Driving Solutions for Patient Healthcare through Innovation, Collaboration and Shared Commitment When industry, academia, the U.S. government and scientific and professional societies share a common vision to address a medical supply need, the results can benefit patient healthcare. Such was the case in securing a reliable domestic supply of molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m), for the United States. Read more… READ MORE » DECEMBER 12, 2018 NEWS Molecular Imaging News: A New Link in the Chain Medical radioisotopes are crucial components of modern health care, but the supply chain that ensures access to them is fragile. For example, SNMMI issued a molybdenum-99 (Mo-99) shortage alert for the first half of November, due to a continuing outage at a reactor in South Africa and an unanticipated shutdown of a reactor in the […] READ MORE » MAY 14, 2018 NEWS Made in the USA: Department of Energy Labs Help Advance Technology to Ensure Supply of Key Medical Isotopes – ORNL, others provide R&D help to make molybdenum-99 and technetium-99m without highly enriched uranium – “Made in the USA.” That can now be said of the radioactive isotope molybdenum-99 (Mo-99), last made in the United States in the late 1980s. Read more… READ MORE » MARCH 30, 2018 NEWS FDA Clears Path for First Domestic Supply of Tc-99m Isotope The U.S. Food and Drug Administration (FDA) and the Nuclear Regulatory Commission (NRC) took steps in February to ensure a stable and secure supply of a critical radioactive imaging tracer used to detect potentially life-threatening diseases. Read more… READ MORE » FEBRUARY 21, 2018 NEWS FDA approves new way to make medical imaging isotope – System will be the US’s first domestic source of molybdenum-99 for 30 years – The US Food and Drug Administration (FDA) has approved a new system for generating the diagnostic radioisotope technetium-99m that it hopes will address shortages. Read more… READ MORE » FEBRUARY 9, 2018 NEWS FDA Nod for NorthStar Device Clears Way to Make Medical Radioisotope A Wisconsin company has moved one step closer to becoming the first domestic producer in decades of a crucial medical radioisotope after receiving a key approval from the FDA on Thursday. Read more… READ MORE » FEBRUARY 8, 2018 NEWS U.S. OKs medical isotope system not based on bomb-grade uranium WASHINGTON (Reuters) – The U.S. federal government on Thursday approved a device made by a private company in Wisconsin that will allow the first domestic production of a medical imaging isotope in 25 years, a move the government said would enhance national security by reducing the need to transport weapons-grade uranium. Read more… READ MORE » FEBRUARY 8, 2018 NEWS DOE/NNSA Partnership With U.S. Healthcare Industry Results in FDA Approval of Domestically-Produced, Non-Uranium Based Molybdenum-99 WASHINGTON – Efforts by the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) to ensure a reliable supply of a vital medical isotope have paved the way for today’s announcement by the U.S. Food and Drug Administration (FDA) on the approval of the first domestically-produced, non-uranium based molybdenum-99 (Mo-99). Read more… READ MORE » FEBRUARY 8, 2018 NEWS Statement from FDA Commissioner Scott Gottlieb, M.D., on groundbreaking approval and interagency approach to bring stable supply of critical medical imaging isotope to the U.S. Today, I’m proud to acknowledge the role the FDA played in the groundbreaking effort to develop a new imaging technology – the RadioGenix System. Read more… READ MORE » FEBRUARY 8, 2018 NEWS DOE/NNSA partnership with U.S. healthcare industry results in FDA approval of domestically-produced, non-uranium based Molybdenum-99 WASHINGTON – Efforts by the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) to ensure a reliable supply of a vital medical isotope have paved the way for today’s announcement by the U.S. Food and Drug Administration (FDA) on the approval of the first domestically-produced, non-uranium based molybdenum-99 (Mo-99). Read more… READ MORE » FEBRUARY 8, 2018 NEWS FDA Media Availability FDA Media Transcripts: https://www.fda.gov/NewsEvents/Newsroom/MediaTranscripts/default.htm Listen to FDA Media Briefing: [player id=1469] READ MORE » FEBRUARY 8, 2018 NEWS FDA and NRC pave way for the first domestic supply of the most commonly used medical isotope in diagnostic imaging FDA and NRC pave way for the first domestic supply of the most commonly used medical isotope in diagnostic imaging. Read more… READ MORE » JULY 22, 2016 NEWS Intuitive PETG Thermoformed Package Shines for NorthStar NorthStar Medical Radioisotopes’ Radiogenix™ Isotope Separation System’s product packaging is convenient, intuitive, creative and unconventional. Read more… READ MORE » NOVEMBER 14, 2014 NEWS NNSA announces funding for isotope projects According to NNSA, NorthStar Medical Radioisotopes is to receive $5.2 million to further develop its technology to produce Mo-99 via neutron capture, bringing the total NNSA support for the project to $16.1 million to date. Read more… READ MORE » AUGUST 18, 2014 NEWS NorthStar will supply GE with Mo-99 NorthStar also signed a similar agreement with Triad Isotopes, Inc. in June. Read more… READ MORE » AUGUST 14, 2014 NEWS NorthStar Medical Radioisotopes Signs Letter of Intent with GE Healthcare MADISON, Wis., Aug 14, 2014 (BUSINESS WIRE) — NorthStar Medical Radioisotopes LLC has signed a non-exclusive letter of intent with GE Healthcare, a division of General Electric Company GE, -0.42% marking further progress toward establishing the first existing commercially viable domestic source of the radioisotope 99molybdenum (99Mo). Read more… READ MORE » JULY 17, 2014 NEWS NorthStar building to begin Twelve years ago George Messina met with a scientist about a new patent that would likely change how medical diagnostic testing would be done in the United States. Read more… READ MORE » JULY 16, 2014 NEWS North Star Medical Expansion to Bring 150 Jobs to Beloit BELOIT (WIFR) — One medical company is bringing more jobs to the Beloit area, but that may not be the biggest factor of the move. Read more… READ MORE » JULY 16, 2014 NEWS NorthStar Medical Radioisotopes: Breaks ground for new facility in Beloit, Wis. BELOIT, Wis. – NorthStar Medical Radioisotopes LLC broke ground today for a new 50,000-square-foot facility at 1800 Gateway Blvd. in Beloit, Wis. When completed in late 2014, the facility will house the company’s headquarters and activities related to the production of the medical radioisotope molybdenum-99 (Mo-99). Read more… READ MORE » MAY 22, 2012 NEWS Wanted: Money for entrepreneurs Everybody loves the entrepreneur, the little guy or gal with the big idea who launches and expands a business. Politicians of every stripe correctly tout start-up companies as key to creating more jobs. Read more… READ MORE » NOVEMBER 5, 2011 NEWS Race for isotope shows Wisconsin’s strength What does it say about a state’s innovation-based economy when it boasts not one but two of the four U.S. companies racing to produce a medical isotope so essential that it’s used in 50,000 clinical tests per day? Read more… READ MORE » NOVEMBER 1, 2011 NEWS NNSA Signs Cooperative Agreement to Produce Molybdenum-99 in the United States without the use of Highly Enriched Uranium WASHINGTON, D.C. – The National Nuclear Security Administration’s (NNSA) Global Threat Reduction Initiative announced today the signing of a cooperative agreement with NorthStar Medical Radioisotopes, LLC, to further the development of accelerator-based technology to produce molybdenum-99 (Mo-99) in the United States. Read more… READ MORE » NOVEMBER 1, 2011 NEWS Nuclear agency to share cost of developing Beloit plant NorthStar Medical Radioisotopes LLC said Tuesday it has signed a $4.6 million agreement with the National Nuclear Security Administration that will help the Madison company develop architectural and site plans for a Beloit plant to produce medical isotopes. Read more… READ MORE » SEPTEMBER 18, 2011 NEWS NorthStar Finds Way to Produce Medical Isotope Quickly, Safely As problems go, NorthStar Medical Radioisotopes LLC was founded on a big one. Production issues at several nuclear power plants outside the U.S. during the last few years and worries about nuclear proliferation prompted the federal government in 2009 to look for ways to make a critical medical isotope more safely and closer to home. Read more… READ MORE » SEPTEMBER 12, 2011 NEWS NorthStar to produce Mo-99 isotope with GE Hitachi, Exelon NorthStar Medical Radioisotopes has entered a tentative deal with GE Hitachi Nuclear Energy and Exelon for the production of the medical isotope molybdenum-99. Read more… READ MORE » SEPTEMBER 12, 2011 NEWS Beloit plant could produce key medical isotope NorthStar Medical Radioisotopes LLC, a Madison nuclear medicine company, has signed a tentative agreement for its Beloit facility to process radioactive material into a key isotope used for medical procedures. Read more… READ MORE » AUGUST 11, 2011 NEWS BioForward Announces Winners of 2011 Bioscience Vision Summit’s Emerging Company Showcase MADISON, Wis.–(BUSINESS WIRE)–Six Wisconsin bioscience companies have been selected as the winners of BioForward’s 2011 Emerging Company Showcase. Read more… READ MORE » JUNE 22, 2011 NEWS High tech jobs may be coming to Beloit NorthStar Medical Radioisotopes, LLC plans to locate a new 82,000 square foot production facility in Beloit. Read more… READ MORE » JUNE 22, 2011 NEWS NorthStar Medical to build $194 million plant in Beloit NorthStar Medical Radioisotopes LLC is planning to build a $194 million production plant in Beloit that could employ as many as 150 people by 2016. Read more… READ MORE » JUNE 22, 2011 NEWS NorthStar medical firm to build plant in Beloit NorthStar Medical Radioisotopes, Madison, will build an 82,000-square-foot manufacturing plant in Beloit. Read more… READ MORE » JUNE 22, 2011 NEWS NorthStar Medical to build $194 million radioisotopes plant in Beloit NorthStar Medical Radioisotopes LLC is planning to build a $194 million production plant in Beloit that could employ as many as 150 workers by 2016. Read more… READ MORE » JUNE 22, 2011 NEWS High-tech firm picks Beloit for $194 million development A highly-specialized company serving the needs of the nuclear medicine market plans to locate its $194 million, 82,000-square foot production facility in Beloit. Read more… READ MORE » 1800 Gateway Boulevard Beloit, WI 53511 Phone: (844) GET-MOLY Phone: (608) 313-8000 OUR PRODUCTS DEVELOPMENT COMPANY CAREERS SEARCH HOW CAN WE HELP? Questions about our company, products, supply solutions, careers or anything else? CONTACT US ©2021 NorthStar Medical Radioisotopes, LLC. All rights reserved. Privacy Policy. Terms & Conditions.